Prof. Lucio Frydman

The emphasis of these studies will be tailoring the ultrahigh field, multinuclear capabilities available at our Institute (15.2T animal MRI, 7T human MRI, 18.8T microimaging) for optimizing the information available from CEST, from 1H MRS, and the imaging of metabolism and fluxes via low-gamma --mostly quadrupolar (e.g., 2H)-- nuclei (Magn. Reson. Med., 86, 2604, 2021 - cover of November issue; Metabolites, 11, 376, 2021; NMR Biomed., 33, e4208, 2020 - cover of March issue; NMR Biomedicine, 31, e3995, 2018 - cover of November issue; Proc. Natl. Acad. Sci. USA, 115, E2429, 2018). These researches will complement related activities going on in our group in the areas of biomolecular NMR, ultrafast NMR/MRI acquisition techniques, and MRI human imaging, providing a unique experience for the pursuit of an academic or high tech career for scientists at the interface of biological and medical physics

Further information on our group’s activities can be found in https://www.weizmann.ac.il/chemphys/Frydman_group